2020-2030 POC HbA1C Testing Market Opportunity And Forecasts Analysis

LONDON, March 31, 2020 /PRNewswire/ -- TheBusinessResearchCompany.com offers "POC HbA1C Testing Market By Product (Instruments, Consumables), By Technology (Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, Others), By End-User (Hospitals, Home Care, Others), And Geography | Global Forecast To 2023" report from its latest research collection. The complete report with TOC is spread across 319 pages and readily available for purchase. Make a Direct Purchase Order of This Report (Individual License USD 4000) @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2571 .


Advances In Testing Technologies In The $483.8 Million POC Hba1c Testing Market

Technological advances in point of care (POC) hemoglobin (Hb) A1C testing are helping laboratories to conduct the tests more efficiently. Major players in the market are investing in developing advanced technologies to provide fast, accurate results in a short period, thereby helping laboratories to manage the increase in demand for testing. For instance, in June 2019, Abbott introduced Afinion(TM) HbA1c Dx assay, an in vitro diagnostic test for the quantitative determination of HbA1c in human venous and capillary whole blood, for use on the Afinion 2 Analyzer, and also Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the only rapid POC test cleared by the U.S. Food and Drug Administration (FDA) to assist healthcare professionals in diagnosing diabetes and also determining the patients' risk of developing the disorder. The test provides reliable and accurate results of 1,2 glycated hemoglobin in just three minutes, helping physicians to evaluate patients and enable them to formulate individualized care plans during a single visit to the doctor's office. These developments will aid the growth of the POC HbA1C testing market. Read More On The Business Research Company's POC Hba1c Testing Market Report @ https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-market

POC Hba1c Testing Market Segments

The POC HbA1C testing devices assess the average level of blood sugar over 2 to 3 months in an individual. POC HbA1C testing devices are designed to diagnose average levels of glucose in patients' blood and to control type I and type II diabetes mellitus. The POC HbA1C testing devices market is segmented based on the type of product into instruments, and consumables; by technology into ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay, and others; and by end-user into hospitals, physician office/outpatient center, home care, and others.

Changing Lifestyles Will Drive The POC HbA1C Testing Market

The global POC HbA1C testing market reached a value of nearly $483.8 million in 2019, having grown at a compound annual growth rate (CAGR) of 6.37% since 2015, and is expected to grow at a CAGR of 8.0% to nearly $658.6 million by 2023. Changing lifestyles are leading to an increased prevalence of diabetes- type II diabetes in particular- which in turn will drive the market for POC HbA1C testing in the forecast period. Long working hours, less physical activity, and unhealthy eating and drinking habits are increasing the prevalence of diabetes. Globally, the number of diabetic patients is expected to increase to 629 million by 2045. Besides, urbanization is also expected to drive the market in the forecast period. Globally, the percentage of the population living in urban areas is expected to increase from 55% in 2018 and reach 68% by 2050. Changing lifestyles, coupled with the growth in the urban population, the rise in disposable incomes, and affordability among residents of cities will drive the demand for POC HbA1C testing.

Inability Of Testing Devices To Assess All Blood Types- A Market Restraint

The Point of Care (POC) Hemoglobin (Hb) A1C testing market is being restrained by the inability of these devices to assess all blood types. For instance, the HbA1C test is not suitable for patients with African, Mediterranean, or Southeast Asian descent, or having a family member suffering from skin diseases such as sickle cell anemia or thalassemia, as people from this group are expected to have a different type of hemoglobin, known as a hemoglobin variant, which may interfere with the results of HbA1C tests. Moreover, HbA1C test is not recommended in cases where the symptoms are visible for less than 2-3 months since the test measures the average glucose levels in the blood over past 2-3 months only. In such cases, alternative tests such as fructosamine are recommended as it gives a more appropriate measure of glycemic control in blood samples. This inability hinders the growth of the POC HbA1C market.

Request A Sample Of The POC HbA1C Testing Market Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2571&type=smp

Increasing Use Of Home HbA1C Testing Kits

Home HbA1C testing kits allow people with diabetes to measure their HbA1c levels at home. Home HbA1c tests can be carried out within a relatively short period of time. Most home HbA1c tests require a sample of blood from the finger and then the test result may be given in different ways depending on the kit. Some kits provide a numeric result; others may provide a yes or no indicating whether the HbA1c value is above or below a certain number. Currently, due to the Coronavirus disease (COVID-19) pandemic, diabetic patients who seek to keep their distances from hospitals and follow social distancing are increasingly using home kits to identify their risks and seek to maintain and manage their condition at home, whilst limiting their potential exposure to the virus.

Here Is A List Of Similar Reports By The Business Research Company:

Diabetes Care Devices Market By Segments (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors), By Applications, By Trends And By Regions - Global Forecast To 2022

Blood Glucose Test Strips Market Based On Technology (Glucose Oxidase And Glucose Dehydrogenase), By Type (Thick Film Electrochemical Films, Thin Film Electrochemical Films And Optical Strips), By Geography And By Trends - Global Forecast To 2023

Insulin Pens, Syringes, Pumps And Injectors Market Analysis - By Devices (Pens, Injectors And Pumps, Syringes), By End-User (Homecare, Hospitals And Others), By Expenditure (Private, Public Healthcare), And Regions | Global Forecast To 2023

Diabetes Therapies Market By Segments (Injectables And Oral), By Trends, By Regions, By Key Players And Market Size - Global Forecast To 2023

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database:

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_Info

View original content:http://www.prnewswire.com/news-releases/2020-2030-poc-hba1c-testing-market-opportunity-and-forecasts-analysis-301032493.html

SOURCE The Business Research Company